Legend Biotech

After a year of achieving significant milestones, our LEGENDary team toasted our successes for patients and celebrated in seasonal attire with an ugly sweater contest and party to mark the holidays. We are grateful to all our employees for their dedication to the patients we serve each day.  #WeAreLegend #CompanyCulture

Mark your calendars! Our CEO, Ying Huang, will share Legend Biotech’s latest updates at the J.P. Morgan Healthcare Conference on January 14, 2025, at 3:45 p.m. PT.     Learn more and register: https://lnkd.in/gx2CY6dj   #JPMorganHealthcare #CellTherapy #JPMHC2025

That’s a wrap! Our team had a wonderful time at the American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego.    It was a privilege to reconnect with the #hematology and patient advocacy communities at our exhibit booth and those who participated in the live webcast investor event. We are committed to leading the charge for CAR-T as a first-line therapy for cancer in the future. Thanks to all who joined us in meaningful, forward-thinking discussions.  #ASH24 #CellTherapy #CART #MultipleMyeloma

#LegendNews: We are excited to present new findings from our Phase 3 study at this year’s American Society of Hematology (ASH) Annual Meeting & Exposition. This latest data on minimal residual disease (MRD) negativity rates reinforces the strength of our research for those with #MultipleMyeloma. Learn more: https://bit.ly/3BmRJSw #ASH24 #CART

We are heading to the American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego this weekend!    Don’t miss our oral presentation on minimal residual disease (MRD) negativity rates and three poster presentations. Be sure to stop by our exhibit at #2805.    We look forward to reconnecting with many of our friends and colleagues!    Find more about our presentations: https://bit.ly/41hmUJs    #ASH24 #CellTherapy #MultipleMyeloma #CART

Today we celebrate #NationalFamilyCaregiversMonth by honoring those who tirelessly support their loved ones. Every day caregivers make a significant difference in patients’ lives, and their dedication does not go unnoticed. At Legend Biotech, we are committed to improving the health and quality of life of those in our community. Learn more about how we prioritize patients in our ESG Report: https://lnkd.in/eZ-PxPWZ  #NFCMonth #WeAreLegend 

November is Stomach Cancer Awareness Month, and World Pancreatic Cancer Day is today, November 21st. At Legend Biotech, we are advancing research of cell therapies to treat #PancreaticCancer and #GastricCancer. Learn more about our R&D efforts: https://lnkd.in/eNs5VmNJ #StomachCancerAwarenessMonth #PancreaticCancerAwarenessMonth #CellTherapy 

#LegendNews: We have earned top honors in several categories in the mid-cap biotech sector, as recognized by Extel's 2024 All-America Executive Team awards. Congrats to Ying Huang, PhD, Lori Macomber, Jessie Yeung, our board, and the whole IR team.    This honor underscores our pioneering efforts in revolutionizing CAR-T #CellTherapy to cure cancer. We appreciate your support as we work to create breakthrough cancer treatments.   #WeAreLegend

The Advanced Practitioner Society For Hematology And Oncology (APSHO)’s 2024 #JADPROLive exhibit opens today! If you’re attending, stop by our booth (#1016) to chat with our team and learn more about #CellTherapy for #MultipleMyeloma. See you there! #Oncology #Hematology #Nurses #AdvancedPractitioners

We recognize the challenges and gaps in care for those with small cell lung cancer (#SCLC). Our Chief Medical Officer, Mythili Koneru, shares how we remain motivated by our mission to develop cutting-edge cell therapies to support patients’ unmet needs. #LungCancer #LungCancerAwarenessMonth #CellTherapy